XML 14 R4.htm IDEA: XBRL DOCUMENT v3.25.3
Interim Condensed Consolidated Statements of Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Revenues:        
Revenues $ 28,384 $ 27,207 $ 78,307 $ 77,716
Cost of revenues 3,392 3,961 10,428 9,397
Gross profit 24,992 23,246 67,879 68,319
Operating expenses:        
Research and development, net 19,532 17,990 55,899 54,739
Sales and marketing 3,012 3,088 9,783 8,999
General and administrative 4,383 4,642 12,697 11,751
Amortization of intangible assets 149 150 448 449
Total operating expenses 27,076 25,870 78,827 75,938
Operating loss (2,084) (2,624) (10,948) (7,619)
Financial income, net 1,245 2,299 5,466 4,962
Remeasurement of marketable equity securities 1 21 (261) (97)
Loss before taxes on income (838) (304) (5,743) (2,754)
Income tax expense 1,671 1,007 3,797 4,296
Net loss $ (2,509) $ (1,311) $ (9,540) $ (7,050)
Weighted-average shares used to compute net loss per share (in thousands):        
Basic and diluted (in shares) 23,942 23,678 23,869 23,605
License [Member]        
Revenues:        
Revenues $ 16,028 $ 15,574 $ 46,092 $ 44,266
Royalty [Member]        
Revenues:        
Revenues $ 12,356 $ 11,633 $ 32,215 $ 33,450